Bridget A. Ross - 08 Aug 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ Nathan Ulrich
Issuer symbol
LMAT
Transactions as of
08 Aug 2025
Transactions value $
-$141,775
Form type
4
Filing time
13 Aug 2025, 08:55:24 UTC
Previous filing
02 Jun 2025
Next filing
08 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ross Bridget A Director C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON /s/ Nathan Ulrich 12 Aug 2025 0001698518

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $93.2K +2.5K +85.73% $37.29 5.42K 08 Aug 2025 Direct F1
transaction LMAT Common Stock Sale -$235K -2.5K -46.16% $94.00 2.92K 08 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -2.5K -100% $0.00 0 08 Aug 2025 Common Stock 2.5K $37.29 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 This option is fully vested and exercisable.